Kenneth Bate Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 13 hours ago
Kenneth Bate has an estimated net worth of at least $12.9 million*, as of Aug. 20, 2025. They own 12,489 shares of MDGL stock. They have sold 42,489 shares of MDGL stock since 2021, for an estimated $11.9 million.
Kenneth Bate $MDGL SEC Form 4 Insider Trading
Kenneth Bate has filed a total of 23 insider trades in $MDGL since 2021. Their most recent trade was a sale of 2,317 shares, made on Aug 15, 2025. Their largest trade was a sale of 7,411 shares, made on Apr 01, 2024. We estimate that they now own 12,489 shares of $MDGL, worth an estimated $1.0 million.
Insider Trading at $MDGL
There have been a total of 496 insider trades reported at $MDGL since 2021, with 590,368 shares purchased and 736,215 shares sold. The most active insider traders in $MDGL stock have been Brian Joseph Lynch, Rebecca Taub, and Robert E. Waltermire. The most recent trade was a sale of 6,485 shares reported by William John Sibold (President and CEO), made on Aug 21, 2025.
History of Insider Stock Trades by Kenneth Bate
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MDGL
|
Sale | 2,317 | Aug 15, 2025 | Aug. 15, 2025, 6:04 p.m. |
|
MDGL
|
Sale | 2,516 | Aug 15, 2025 | Aug. 15, 2025, 6:04 p.m. |
|
MDGL
|
Sale | 2,567 | Aug 15, 2025 | Aug. 15, 2025, 6:04 p.m. |
|
MDGL
|
Sale | 600 | Aug 15, 2025 | Aug. 15, 2025, 6:04 p.m. |
|
MDGL
|
Sale | 1,104 | Aug 15, 2025 | Aug. 15, 2025, 6:04 p.m. |
|
MDGL
|
Sale | 896 | Aug 15, 2025 | Aug. 15, 2025, 6:04 p.m. |
|
MDGL
|
Sale | 6,698 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 7,411 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 2,790 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 2,104 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 200 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 841 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 143 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 116 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 700 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 274 | Apr 01, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 1,217 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 7,048 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 2,080 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 567 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 100 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 193 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
|
MDGL
|
Sale | 7 | Apr 02, 2024 | April 3, 2024, 8:44 p.m. |
$MDGL Executives and Stock Owners with Insider Trades
-
Brian Joseph Lynch, SVP and General Counsel
-
Rebecca Taub, Pres., R&D, and CMO
-
Robert E. Waltermire, Senior VP, Chief Pharma Dev.
-
Remy Sukhija, Chief Commercial Officer
-
Carole Huntsman, Chief Commercial Officer
-
Shannon T Kelley, General Counsel
-
William John Sibold, President and CEO
-
Mardi Dier, SVP and CFO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.